AWM
ESPR

Apollon Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

Apollon Wealth Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$9.84K – 1336
2025
Q2 		$9.84K Sell
10,000
-29
-0.3% -$29 ﹤0.01% 1269
2025
Q1 		$14.4K Buy
10,029
+29
+0.3% +$53 ﹤0.01% 1201
2024
Q4 		$22K Hold
10,000
– – ﹤0.01% 1185
2024
Q3 		$16.5K Hold
10,000
– – ﹤0.01% 1126
2024
Q2 		$22.2K Hold
10,000
– – ﹤0.01% 1091
2024
Q1 		$26.8K Buy
+10,000
New +$24.3K ﹤0.01% 1099

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return